Tecnovatica S.A. (WSE:TEC)

Market Cap	6.19M -6.3%
Revenue (ttm)	52.62K +163.1%
Net Income	69.77K
EPS	0.01
Shares Out	10.75M
PE Ratio	88.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,299
Average Volume	24,244
Open	0.6000
Previous Close	0.5760
Day's Range	0.5780 - 0.6140
52-Week Range	0.2280 - 0.7950
Beta	0.22
RSI	62.37
Earnings Date	Apr 2, 2026

About Tecnovatica

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC